Tirzepatide 30mg

$52.00

A dual GIP and GLP-1 receptor agonist used in incretin signalling and metabolic research.

Certificate of analysis

Testing in progress

Third-party analysis in progress. Certificate published on completion.

This lot is currently with an independent US-based analytical laboratory. The full certificate, including the HPLC chromatogram, mass-spectrometry identity confirmation and lot number, will be published here before the batch is released for sale. We do not list placeholder or sample certificates.

Research use only

This product is supplied for laboratory research use by qualified researchers. It is not a drug, food, cosmetic or medical device. It is not for human or veterinary consumption, and it is not intended to diagnose, treat, cure or prevent any disease. The purchaser assumes full responsibility for safe handling and for lawful use in their jurisdiction.

9 in stock

SKU: TIRZEPATIDE-30MG Category:

A dual GIP and GLP-1 receptor agonist used in incretin signalling and metabolic research.

Supplied as lyophilised powder in a sealed 3 mL borosilicate vial. Released to a specification of ≥98% purity by HPLC. Each batch is analysed by an independent US-based analytical laboratory and the certificate of analysis is published on this page before the batch is released.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY CONSUMPTION. Supplied for laboratory research use by qualified researchers. Not a drug, food, cosmetic or medical device. Not intended to diagnose, treat, cure or prevent any disease. The purchaser assumes full responsibility for safe handling and lawful use in their jurisdiction.

CAS Number

2023788-19-2

Molecular Formula

C225H348N48O68

Molecular Weight

4813.45 g/mol

Sequence

Pending verification

Appearance

White to off-white lyophilised powder

Release Specification

≥98% purity by HPLC

Presentation

30mg lyophilised powder, 3 mL borosilicate vial

Storage

-20 °C, protected from light

Country of Dispatch

United States